FDA Clearance Tracker · K121874
G7 ACETABULAR SYSTEM
Last checked: Nov 20, 2026Latest source record: Nov 23, 2012 (this decision)Source: openFDAMethods & limitations
Decided
Nov 23, 2012
Substantially Equivalent
Time to decision
149 days
Received Jun 27, 2012. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K121874
- Device name
- G7 ACETABULAR SYSTEM
- Applicant
- Biomet Manufacturing Corp
- Applicant location
- Warsaw, IN
- Received
- Jun 27, 2012
- Decided
- Nov 23, 2012
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 888.3310
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code PBI (Prosthesis, Hip, Constrained, Cemented Or Uncemented, Metal/Polymer, + Additive).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K121874
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Biomet Manufacturing Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Oxford Cementless Partial Knee SystemPMA supplement
P010014-S105 · Decided Nov 22, 2024 · 536 days after receipt · Panel Track
Device type: Prosthesis, knee, femorotibial, unicompartmental, semi-constrained, metal/polymer, mobile bearing (NRA) · Orthopedic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.